To investigate the function of GLUT1 in septic arthritis, we designed a model in which WZB117, a selective irreversible inhibitor of GLUT1 (Liu et al, 2012), was injected into the knee joint after combined antibiotic treatment (Fig 3A). The gene discussed is SLC2A1; the disease is bacterial arthritis.